Luminex Company Profile

20:31 EDT 23rd March 2018 | BioPortfolio

Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life-sciences industry. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.Systems using xMAP technology (formerly known as LabMAP®) perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.


12212 Technology Blvd
United States of America


Phone: 512.219.8020 or 888.219.8020
Fax: 512.219.5195

News Articles [19 Associated News Articles listed on BioPortfolio]

Luminex receives FDA clearance for ARIES Group A Strep assay

Luminex announced that it has received FDA clearance for the ARIES Group A Strep assay, a moderate complexity, sample to answer test for the direct detection of Streptococcus pyogenes from throat swab...

Can Luminex Light The Way?

Luminex’s Tadd Lazarus Joins Clinical Genomics as Chief Medical Officer

Tadd Lazarus has joined cancer tests company Clinical Genomics as chief medical officer. Before coming to the Bridgewater, NJ-based company, Lazarus was senior vice president and chief medical officer...

Luminex (LMNX) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

Luminex's (LMNX) CEO Homi Shamir on Q3 2017 Results - Earnings Call Transcript

Luminex Corporation (LMNX) CEO Homi Shamir on Q4 2017 Results - Earnings Call Transcript

Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

The investor presentation will begin at 8:00 a.m. Eastern timeon Wednesday, November 29, 2017.  The presentation will be webcast live and may be accessed Read more...

Luminex Corporation Reports Third Quarter 2017 Financial Results

"The tremendous momentum in our sample-to-answer molecular business drove the Company's performance this quarter. Our VERIGENE and ARIES systems are experiencing excellent traction in the Read mor...

Drugs and Medications [0 Results]


PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Comparison of the Luminex NxTAG respiratory pathogen panel and a multiplex in-house real-time PCR panel for the detection of respiratory viruses in symptomatic patients.

To evaluate the Luminex NxTAG respiratory pathogen panel (NxTAG RPP) for the detection of respiratory viruses in clinical samples from patients with the symptoms of respiratory infection.

The good, the bad and the ugly of luminex donor specific cross match.

The presence of donor specific antibodies directed against human leukocyte antigen significantly influences renal transplant due to antibody mediated rejection (AMR). We performed the screening of pre...

The performance of Luminex ARIES(®) Flu A/B & RSV and Cepheid Xpert(®) Flu/RSV XC for the detection of influenza A, influenza B, and respiratory syncytial virus in prospective patient samples.

The demand for rapid, accurate viral testing has increased the number of assays available for the detection of viral pathogens. One of the newest FDA cleared platforms is the Luminex ARIES(®) Flu A/B...

Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.

We used the Luminex Bead Array Multiplex Immunoassay to measure cytokines, chemokines and growth factors responses to the same antigens used for RD1-based Interferon γ Release Assay (IGRA) test. Seve...

Enterovirus detection in patients with acute gastroenteritis in Switzerland.

Acute gastroenteritis (GE) has a major impact on morbidity and mortality worldwide, yet comprehensive data regarding infectious agents including enteroviruses are scarce. We hypothesized that enterovi...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Cytokine Evaluation of Accelerated Tooth Movement

Gingival Crevicular Fluid samples will be collected using periopapers after accelerated tooth movement technique, results will be achieve with cytokine measurements that will be done using...

Fluency Stent-Graft Versus Luminex Stent for Angioplasty of Recurrent Stenosis of the Cephalic Arch in Autogenous Arteriovenous (AV) Access for Hemodialysis

The type of hemodialysis access and preservation of this access greatly influences the quality of life and survival of patients undergoing hemodialysis. The Kidney Disease Outcomes Quality...

Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects

This is a phase i randomized, double blind clinical trial designed to evaluate the safety, tolerability and immunogenicity of the ID93 recombinant protein antigen alone or formulated with ...

ZRx-101 (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia

The ZRx-101 cells have features similar to activated NK cells, but mediate superior anti-tumor activity against hematologic and solid tumor targets in vitro and in vivo. The utilization of...

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects

This is a China registration study. A randomized, double-blind, placebo-controlled immunogenicity and safety study in Chinese female subjects aged 9 to 45 years and male subjects aged 9 to...

Companies [4 Associated Companies listed on BioPortfolio]


Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biologic...

Luminex Corp.

Luminex Corporation

One Lambda Inc.

One Lambda Inc. is a world leader in the manufacture of HLA medical diagnostic products based in Canoga Park, California. The company is committed to develop products that improve...

More Information about "Luminex" on BioPortfolio

We have published hundreds of Luminex news stories on BioPortfolio along with dozens of Luminex Clinical Trials and PubMed Articles about Luminex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Luminex Companies in our database. You can also find out about relevant Luminex Drugs and Medications on this site too.

Quick Search


Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record